Wall Street brokerages forecast that Olin Co. (NYSE:OLN) will report $1.70 billion in sales for the current fiscal quarter, Zacks Investment Research reports. Two analysts have provided estimates for Olin’s earnings. The highest sales estimate is $1.72 billion and the lowest is $1.68 billion. Olin reported sales of $1.62 billion in the same quarter last year, which would suggest a positive year over year growth rate of 4.9%. The firm is scheduled to issue its next earnings report on Tuesday, February 5th.

On average, analysts expect that Olin will report full year sales of $7.04 billion for the current fiscal year, with estimates ranging from $6.99 billion to $7.10 billion. For the next financial year, analysts anticipate that the firm will post sales of $7.38 billion, with estimates ranging from $7.25 billion to $7.55 billion. Zacks Investment Research’s sales calculations are a mean average based on a survey of research firms that that provide coverage for Olin.

Olin (NYSE:OLN) last issued its quarterly earnings data on Monday, October 29th. The specialty chemicals company reported $0.66 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.75 by ($0.09). Olin had a return on equity of 10.70% and a net margin of 11.02%. The company had revenue of $1.87 billion for the quarter, compared to the consensus estimate of $1.80 billion. During the same period in the prior year, the company earned $0.31 EPS. The firm’s revenue was up 20.4% on a year-over-year basis.

Several equities research analysts have recently issued reports on OLN shares. TheStreet raised shares of Olin from a “c+” rating to a “b” rating in a research report on Wednesday, August 1st. Standpoint Research began coverage on shares of Olin in a research report on Tuesday, August 28th. They issued a “buy” rating and a $20.00 target price for the company. Morgan Stanley set a $38.00 target price on shares of Olin and gave the company a “buy” rating in a research report on Wednesday, September 26th. Citigroup decreased their target price on shares of Olin from $33.00 to $26.00 and set a “buy” rating for the company in a research report on Thursday, November 1st. Finally, Barclays decreased their target price on shares of Olin from $29.00 to $24.00 and set an “equal weight” rating for the company in a research report on Wednesday, October 31st. Two research analysts have rated the stock with a sell rating, four have given a hold rating and seven have assigned a buy rating to the stock. Olin currently has an average rating of “Hold” and an average target price of $31.91.

Shares of OLN stock opened at $20.80 on Wednesday. The company has a quick ratio of 1.13, a current ratio of 1.81 and a debt-to-equity ratio of 1.14. Olin has a 12-month low of $18.49 and a 12-month high of $38.84. The firm has a market cap of $3.68 billion, a PE ratio of 25.68, a P/E/G ratio of 0.31 and a beta of 1.75.

The firm also recently announced a quarterly dividend, which will be paid on Monday, December 10th. Investors of record on Friday, November 9th will be given a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a yield of 3.85%. The ex-dividend date of this dividend is Thursday, November 8th. Olin’s dividend payout ratio (DPR) is currently 98.77%.

In other Olin news, Director Scott Mcdougald Sutton bought 15,000 shares of the firm’s stock in a transaction that occurred on Thursday, November 1st. The stock was acquired at an average price of $21.62 per share, with a total value of $324,300.00. Following the completion of the transaction, the director now owns 15,000 shares in the company, valued at $324,300. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 1.70% of the stock is currently owned by company insiders.

Several institutional investors and hedge funds have recently made changes to their positions in OLN. Oregon Public Employees Retirement Fund lifted its stake in shares of Olin by 3.0% during the 2nd quarter. Oregon Public Employees Retirement Fund now owns 65,437 shares of the specialty chemicals company’s stock worth $1,879,000 after buying an additional 1,880 shares during the last quarter. Envestnet Asset Management Inc. lifted its stake in shares of Olin by 16.3% during the 2nd quarter. Envestnet Asset Management Inc. now owns 14,595 shares of the specialty chemicals company’s stock worth $419,000 after buying an additional 2,043 shares during the last quarter. Vident Investment Advisory LLC lifted its stake in shares of Olin by 6.1% during the 2nd quarter. Vident Investment Advisory LLC now owns 36,622 shares of the specialty chemicals company’s stock worth $1,052,000 after buying an additional 2,105 shares during the last quarter. Aperio Group LLC lifted its stake in shares of Olin by 7.0% during the 2nd quarter. Aperio Group LLC now owns 36,416 shares of the specialty chemicals company’s stock worth $1,046,000 after buying an additional 2,385 shares during the last quarter. Finally, Financial Engines Advisors L.L.C. lifted its stake in shares of Olin by 3.7% during the 2nd quarter. Financial Engines Advisors L.L.C. now owns 75,058 shares of the specialty chemicals company’s stock worth $2,156,000 after buying an additional 2,700 shares during the last quarter. 87.60% of the stock is owned by institutional investors.

Olin Company Profile

Olin Corporation manufactures and distributes chemical products in the United States and internationally. It operates through three segments: Chlor Alkali Products and Vinyls; Epoxy; and Winchester. The Chlor Alkali Products and Vinyls segment offers chlorine and caustic soda, ethylene dichloride and vinyl chloride monomers, methyl chloride, methylene chloride, chloroform, carbon tetrachloride, perchloroethylene, trichloroethylene and vinylidene chloride, hydrochloric acid, hydrogen, bleach products, and potassium hydroxide.

Further Reading: S&P 500 Index

Get a free copy of the Zacks research report on Olin (OLN)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Olin (NYSE:OLN)

Receive News & Ratings for Olin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Olin and related companies with MarketBeat.com's FREE daily email newsletter.